173 related articles for article (PubMed ID: 37985179)
21. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
[TBL] [Abstract][Full Text] [Related]
22. Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.
Kibaly C; Lin HY; Loh HH; Law PY
Pharmacol Res; 2017 May; 119():153-168. PubMed ID: 28179123
[TBL] [Abstract][Full Text] [Related]
23. Hsp90β positively regulates μ-opioid receptor function.
Zhang Y; Zhou P; Wang Z; Chen M; Fu F; Su R
Life Sci; 2020 Jul; 252():117676. PubMed ID: 32304763
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
25. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
Connor M; Bagley EE; Chieng BC; Christie MJ
Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
[TBL] [Abstract][Full Text] [Related]
26. Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.
Chakrabarti S; Liu NJ; Gintzler AR
Cell Mol Neurobiol; 2021 Jul; 41(5):855-862. PubMed ID: 32804312
[TBL] [Abstract][Full Text] [Related]
27. Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice.
Varga AG; Reid BT; Kieffer BL; Levitt ES
J Physiol; 2020 Jan; 598(1):189-205. PubMed ID: 31589332
[TBL] [Abstract][Full Text] [Related]
28. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.
Johnson EE; Chieng B; Napier I; Connor M
Br J Pharmacol; 2006 Aug; 148(7):947-55. PubMed ID: 16783402
[TBL] [Abstract][Full Text] [Related]
29. Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.
Corder G; Tawfik VL; Wang D; Sypek EI; Low SA; Dickinson JR; Sotoudeh C; Clark JD; Barres BA; Bohlen CJ; Scherrer G
Nat Med; 2017 Feb; 23(2):164-173. PubMed ID: 28092666
[TBL] [Abstract][Full Text] [Related]
30. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.
Yu YJ; Arttamangkul S; Evans CJ; Williams JT; von Zastrow M
J Neurosci; 2009 Jan; 29(1):222-33. PubMed ID: 19129399
[TBL] [Abstract][Full Text] [Related]
31. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation.
Trafton JA; Abbadie C; Marek K; Basbaum AI
J Neurosci; 2000 Dec; 20(23):8578-84. PubMed ID: 11102461
[TBL] [Abstract][Full Text] [Related]
32. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats.
Bie B; Pan ZZ
Mol Pain; 2005 Feb; 1():7. PubMed ID: 15813995
[TBL] [Abstract][Full Text] [Related]
33. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
[TBL] [Abstract][Full Text] [Related]
34. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
Merighi S; Gessi S; Varani K; Fazzi D; Stefanelli A; Borea PA
Biochem Pharmacol; 2013 Aug; 86(4):487-96. PubMed ID: 23796752
[TBL] [Abstract][Full Text] [Related]
35. Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.
Sim-Selley LJ; Scoggins KL; Cassidy MP; Smith LA; Dewey WL; Smith FL; Selley DE
Br J Pharmacol; 2007 Aug; 151(8):1324-33. PubMed ID: 17572699
[TBL] [Abstract][Full Text] [Related]
36. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
37. Agonist-dependent postsynaptic effects of opioids on miniature excitatory postsynaptic currents in cultured hippocampal neurons.
Liao D; Grigoriants OO; Loh HH; Law PY
J Neurophysiol; 2007 Feb; 97(2):1485-94. PubMed ID: 17122315
[TBL] [Abstract][Full Text] [Related]
38. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine.
Chakrabarti S; Law PY; Loh HH
Brain Res Mol Brain Res; 1995 Jun; 30(2):269-78. PubMed ID: 7637578
[TBL] [Abstract][Full Text] [Related]
39. μ Opioid Receptor-Triggered Notch-1 Activation Contributes to Morphine Tolerance: Role of Neuron-Glia Communication.
Sanna MD; Borgonetti V; Galeotti N
Mol Neurobiol; 2020 Jan; 57(1):331-345. PubMed ID: 31347026
[TBL] [Abstract][Full Text] [Related]
40. µ-Opioid Receptors Expressed by Intrinsically Photosensitive Retinal Ganglion Cells Contribute to Morphine-Induced Behavioral Sensitization.
Bergum N; Berezin CT; King CM; Vigh J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
